March 2, 2012 — Idiopathic intracranial hypertension (IIH; also called pseudotumor cerebri [PTC] or benign intracranial hypertension) is surprisingly common in patients with systemic lupus ...

Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

WOMAN’S DOCTOR. NO ONE LIKES HAVING A HEADACHE THAT JUST DOESN’T GO AWAY. IT’S JUST THERE FOREVER. BUT ADD VISION ISSUES INTO THE EQUATION AND IT CAN BE REALLY TERRIFYING. THESE ARE SOME OF THE ...

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

A drug used for type 2 diabetes may be able to treat those with ‘blinding’ headaches. The corresponding trial was published in Brain. Blinding headaches, also known as idiopathic intracranial ...

Patients with systemic lupus erythematosus (SLE) with refractory headache warrant further evaluation—particularly if they are children—in order to rule out treatable ailments such as intracranial ...

A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by ...

Although PTC is still often described as benign idiopathic intracranial hypertension, it is actually a very serious condition, and patients may suffer permanent deficits or complications, such as ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do ...